Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.57 +0.01 (+1.41%)
At close: Nov 11, 2026 · 4:00 PM EST

Rani Therapeutics Holdings (RANI) Receivables (2024 - 2026)

Updated

Rani Therapeutics Holdings' Receivables was $2.04 million in Q2 2026, unchanged from the prior quarter.

Analysis

Rani Therapeutics Holdings (RANI) Receivables (2024 - 2026) Analysis & Trends

From Q4 2024 onward, Rani Therapeutics Holdings has reported Receivables for 5 quarters.

  • In earlier years, Receivables was $428,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 25.23 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 18.99 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 13.51 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 12.74 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 16.16 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 10.35 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 5.01 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 14.19 Bn
10 Rani Therapeutics Holdings 111.44 Mn -41.89 Mn - 1.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.96 Mn
Jun 30, 2026 2.04 Mn
Mar 31, 2026 2.04 Mn
Dec 31, 2025 2.04 Mn
Mar 31, 2025 600,000.00
Dec 31, 2024 428,000.00
API Access

Rani Therapeutics Holdings Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=RANI&period=max&api_key=YOUR_API_KEY